New Ebola vaccine enters UK human trials after rapid development

By PulseAugur Editorial · [1 sources] · 2026-07-24 15:16

A new vaccine designed to combat the Bundibugyo strain of the Ebola virus has entered human trials in the UK. The first dose was administered to a volunteer named Ed Hunt at Oxford University. This rapid development, achieved in just eight weeks, utilizes technology similar to AstraZeneca's COVID-19 vaccine, aiming to address the outbreak that has caused over 1,000 deaths in the Democratic Republic of Congo and Uganda. AI

RANK_REASON This is a research milestone involving the first human trial of a new vaccine. [lever_c_demoted from research: ic=1 ai=0.1]

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

SCMP — Tech TIER_1 English(EN) · Agence France-Presse · 2026-07-24 15:16

Ebola virus: first person vaccinated in UK trial of new jab

A volunteer was injected on Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic of Congo (DRC), Oxford University said. More than 1,000 people have been killed in the DRC and Ugand…